The Cooper Companies, Inc. (NASDAQ:COO) Given Consensus Recommendation of “Moderate Buy” by Analysts

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned an average recommendation of “Moderate Buy” from the seventeen research firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $90.7857.

A number of research analysts have recently weighed in on the company. The Goldman Sachs Group reiterated a “sell” rating and set a $73.00 price target on shares of Cooper Companies in a report on Friday, January 9th. Weiss Ratings upgraded Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. Barclays lifted their price target on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, March 6th. Citigroup lowered their price target on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a report on Friday, March 6th. Finally, Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a report on Wednesday, March 4th.

Cooper Companies Stock Performance

Shares of COO stock opened at $63.09 on Wednesday. Cooper Companies has a 1-year low of $61.78 and a 1-year high of $89.83. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $12.31 billion, a price-to-earnings ratio of 31.23, a P/E/G ratio of 1.66 and a beta of 1.07. The stock’s fifty day simple moving average is $73.38 and its 200-day simple moving average is $76.40.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the previous year, the company posted $0.92 earnings per share. Cooper Companies’s revenue for the quarter was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts predict that Cooper Companies will post 4.62 earnings per share for the current fiscal year.

Institutional Trading of Cooper Companies

A number of institutional investors have recently bought and sold shares of the company. Capital World Investors boosted its position in Cooper Companies by 25.7% during the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after purchasing an additional 2,159,233 shares during the last quarter. State Street Corp boosted its position in Cooper Companies by 2.4% during the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after purchasing an additional 207,195 shares during the last quarter. Wellington Management Group LLP boosted its position in Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after purchasing an additional 2,231,568 shares during the last quarter. Finally, Sustainable Growth Advisers LP boosted its position in Cooper Companies by 22.1% during the third quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock valued at $283,327,000 after purchasing an additional 747,476 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.